Literature DB >> 19696980

[Gastrointestinal stromal tumors: recommendations for diagnosis, treatment and aftercare in Austria].

Ferdinand Ploner1, Johannes Zacherl, Friedrich Wrba, Friedrich Längle, Evelyne Bareck, Wolfgang Eisterer, Thomas Kühr, Wolfgang Schima, Michael Häfner, Thomas Brodowicz.   

Abstract

Diagnosis and treatment of gastrointestinal stromal tumors (GIST) requires an interdisciplinary treatment approach. This strategy should be reflected by the content of this article. Austrian representatives of 'GIST relevant' specialties authored this publication on a consensual base. This manuscript should be regarded as a guideline for 'GIST involved' colleagues in Austria.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19696980     DOI： 10.1007/s10354-009-0685-5

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN： 0043-5341


  62 in total

1.  Operative indications for relatively small (2-5 cm) gastrointestinal stromal tumor of the stomach based on analysis of 60 operated cases.

Authors:  Yoshihide Otani; Toshiharu Furukawa; Masashi Yoshida; Yoshiro Saikawa; Norihito Wada; Masakazu Ueda; Tetsuro Kubota; Makio Mukai; Kaori Kameyama; Yoshinori Sugino; Koichiro Kumai; Masaki Kitajima
Journal:  Surgery       Date:  2006-04       Impact factor: 3.982

Review 2.  Laparoscopic treatment of gastric GIST: report of 21 cases and literature's review.

Authors:  Fausto Catena; Monica Di Battista; Pietro Fusaroli; Luca Ansaloni; Valerio Di Scioscio; Donatella Santini; Maria Pantaleo; Guido Biasco; Giancarlo Caletti; Antonio Pinna
Journal:  J Gastrointest Surg       Date:  2007-11-27       Impact factor: 3.452

Review 3.  Gastrointestinal stromal tumors--definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis.

Authors:  M Miettinen; J Lasota
Journal:  Virchows Arch       Date:  2001-01       Impact factor: 4.064

4.  Primary and secondary kinase genotypes correlate with the biological and clinical activity of sunitinib in imatinib-resistant gastrointestinal stromal tumor.

Authors:  Michael C Heinrich; Robert G Maki; Christopher L Corless; Cristina R Antonescu; Amy Harlow; Diana Griffith; Ajia Town; Arin McKinley; Wen-Bin Ou; Jonathan A Fletcher; Christopher D M Fletcher; Xin Huang; Darrel P Cohen; Charles M Baum; George D Demetri
Journal:  J Clin Oncol       Date:  2008-10-27       Impact factor: 44.544

5.  Surgical resection of residual disease in initially inoperable imatinib-resistant/intolerant gastrointestinal stromal tumor treated with sunitinib.

Authors:  W Ruka; P Rutkowski; A Szawłowski; Z Nowecki; M Debiec-Rychter; U Grzesiakowska; W Dziewirski; J A Siedlecki; W Michej
Journal:  Eur J Surg Oncol       Date:  2008-03-04       Impact factor: 4.424

6.  Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033.

Authors:  Charles D Blanke; Cathryn Rankin; George D Demetri; Christopher W Ryan; Margaret von Mehren; Robert S Benjamin; A Kevin Raymond; Vivien H C Bramwell; Laurence H Baker; Robert G Maki; Michael Tanaka; J Randolph Hecht; Michael C Heinrich; Christopher D M Fletcher; John J Crowley; Ernest C Borden
Journal:  J Clin Oncol       Date:  2008-02-01       Impact factor: 44.544

Review 7.  Mutation analysis of gastrointestinal stromal tumors: increasing significance for risk assessment and effective targeted therapy.

Authors:  Eva Wardelmann; Reinhard Büttner; Sabine Merkelbach-Bruse; Hans-Ulrich Schildhaus
Journal:  Virchows Arch       Date:  2007-08-14       Impact factor: 4.064

8.  Prospective multicentric randomized phase III study of imatinib in patients with advanced gastrointestinal stromal tumors comparing interruption versus continuation of treatment beyond 1 year: the French Sarcoma Group.

Authors:  Jean-Yves Blay; Axel Le Cesne; Isabelle Ray-Coquard; Binh Bui; Florence Duffaud; Catherine Delbaldo; Antoine Adenis; Patrice Viens; Maria Rios; Emmanuelle Bompas; Didier Cupissol; Cecile Guillemet; Pierre Kerbrat; Jérome Fayette; Sylvie Chabaud; Patrice Berthaud; David Perol
Journal:  J Clin Oncol       Date:  2007-03-20       Impact factor: 44.544

9.  Single center experience of laparoscopic vs. open resection for gastrointestinal stromal tumors of the stomach.

Authors:  V Pitsinis; A Z Khan; I Cranshaw; W H Allum
Journal:  Hepatogastroenterology       Date:  2007-03

Review 10.  Clinical presentation of gastrointestinal stromal tumors and treatment of operable disease.

Authors:  Peter J Roberts; Burton Eisenberg
Journal:  Eur J Cancer       Date:  2002-09       Impact factor: 9.162
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.